Global Hydrophobic Interaction Chromatography Market Report and Forecast 2024-2032

Global Hydrophobic Interaction Chromatography Market Outlook

The global hydrophobic interaction chromatography market size was valued at USD 366.13 million in 2023, driven by heightened Demand for Monoclonal Antibodies. The market is estimated to grow at a CAGR of 6.9% during the forecast period 2024-2032 to attain a value of USD 667.48 million by 2032.

Heightened Demand for Monoclonal Antibodies to Propel the Global Hydrophobic Interaction Chromatography Industry

Based on sample type, the monoclonal antibodies segment is predicted to account for a significant market share in the hydrophobic interaction chromatography industry. The monoclonal antibodies are duplicated antibodies that are produced artificially through the process of genetic engineering.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The segment growth can be attributed to the increased demand for monoclonal antibodies in cancer treatment, bone marrow transplants, and other applications. In this regard, the hydrophobic interaction chromatography process is used increasingly to purify the monoclonal antibodies. These factors are predicted to aid the market growth in the coming years.

North America to Account for a Substantial Market Share in the Global Hydrophobic Interaction Chromatography Industry

North America is estimated to possess a substantial share of the hydrophobic interaction chromatography industry in the forecast period. This growth can be attributed to the rising incidences of chronic illnesses in the region, which is expected to lead to a heightened demand for antibodies development. For instance, in the US, an estimated number of 1,806,590 cancer cases were reported in 2021. In addition, the rising investments in the funding of research for hydrophobic interaction chromatography are also anticipated to aid the market growth.

Hydrophobic Interaction Chromatography: Market Segmentation

Hydrophobic interaction chromatography refers to the process of separating proteins based on their surface hydrophobicity. It is a popular method of chromatography, as it deploys a less denaturing environment, which helps keep the biological activity of the protein intact. This process also aids in removing impurities and aggregate species that may be present in a solution.

By product, the market is divided into:

• Resins 
• Columns
• Buffers
• Others

On the basis of sample type, the industry can be segmented into:

• Monoclonal Antibodies
• Vaccines
• Others

Based on end user, the market can be categorised into:

• Pharmaceutical and Biopharmaceutical Companies
• CROs and CMOs
• Research and Academic Institutes 
• Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Rising Investments in the Pharmaceutical Sector to Augment the Growth of the Global Hydrophobic Interaction Chromatography Industry

The growing capital expenditure in the pharmaceutical sector is driving the growth of the hydrophobic interaction chromatography industry. The growing geriatric population, which is more likely to contract severe ailments such as autoimmune diseases and others, is also supporting the market. In addition, the rising issues of cancer, such as breast and prostate cancer, are also expected to contribute to the industry growth in the coming years. Moreover, the technological advancements and the rising investments in research and development activities in the healthcare sector are anticipated to propel the market growth over the forecast period.

Key Industry Players in the Global Hydrophobic Interaction Chromatography Market

The report gives a detailed analysis of the following key players in the global hydrophobic interaction chromatography market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

• Bio-Rad Laboratories, Inc.
• GE Healthcare
• Sartorius AG
• Tosoh Bioscience GmbH
• Sepax Technologies, Inc.
• Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

Key Highlights of the Report